Research guide · Skin & Aesthetic Support
KLOW — research protocol
Advanced regenerative + anti-inflammatory blend combining GHK-Cu 50mg, BPC-157 10mg, TB500 10mg and KPV 10mg. Builds on the GLOW formula by adding KPV — an α-MSH tripeptide fragment studied for systemic anti-inflammatory action, gut and skin support. GHK-Cu drives collagen and dermal regeneration, BPC-157 supports connective tissue and gut repair, TB500 promotes vascular and cellular healing, and KPV adds an anti-inflammatory layer that calms the regenerative environment. Together they target the four pillars of recovery: structure (collagen), tissue repair, vascular/cellular renewal and inflammation control — a more complete protocol than any single peptide alone.
This guide summarizes study areas and sources associated with the compound. BioPeptideX does not convert experimental information into a clinical regimen or recommend an individual dose, frequency, route or duration.
Catalog presentations
Concentration table
Mathematical reference only; this is not a dosing recommendation.
This presentation is not expressed solely in milligrams; use the full calculator with the exact label values.
Research areas
- GHK-Cu 50mg + BPC-157 10mg + TB500 10mg + KPV 10mg
- Four-peptide regenerative + anti-inflammatory blend
- 99% HPLC verified purity
- Lyophilized for stability
Limited protocol information
We do not publish a cycle or dose range for this compound because the catalog references are not sufficient to support a responsible regimen. Consult the original publications and a licensed professional.
Handling and storage
Store unreconstituted product according to its label and maintain the cold chain where applicable. After any preparation, follow only validated instructions for the specific product and diluent. Do not use if packaging is damaged or the solution shows particles or unexpected changes.
Warnings
Do not use this page for self-diagnosis or self-medication. Pregnancy, breastfeeding, minors, cancer history, allergies, active disease and concurrent treatments require individual professional evaluation.
Published sources
- 1.Pickart L, Margolina A. Int J Mol Sci, 2018.
- 2.Sikiric P, et al. Curr Pharm Des, 2010.
- 3.Goldstein AL, et al. Ann NY Acad Sci, 2010.
- 4.Brzoska T, et al. Endocr Rev, 2008.